AVITA Medical Inc (RCEL)
8.17
-0.10
(-1.21%)
USD |
NASDAQ |
May 20, 16:00
8.19
+0.02
(+0.24%)
After-Hours: 20:00
AVITA Medical Cash from Financing (Quarterly): 0.631M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.631M |
| December 31, 2023 | 39.43M |
| September 30, 2023 | 0.60M |
| June 30, 2023 | 0.171M |
| March 31, 2023 | 0.171M |
| December 31, 2022 | 0.899M |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.001M |
| September 30, 2021 | 0.003M |
| June 30, 2021 | 0.031M |
| March 31, 2021 | 64.03M |
| December 31, 2020 | -0.005M |
| September 30, 2020 | -0.004M |
| June 30, 2020 | 0.152M |
| March 31, 2020 | 0.065M |
| December 31, 2019 | 76.86M |
| September 30, 2019 | -0.017M |
| June 30, 2019 | 0.7255M |
| March 31, 2019 | 11.12M |
| December 31, 2018 | 15.67M |
| September 30, 2018 | 2.196M |
| June 30, 2018 | 9.026M |
| March 31, 2018 | -0.1957M |
| December 31, 2017 | 12.46M |
| Date | Value |
|---|---|
| September 30, 2017 | |
| June 30, 2017 | 6.331M |
| March 31, 2017 | -6.128M |
| December 31, 2016 | -0.3613M |
| September 30, 2016 | 6.489M |
| June 30, 2016 | 6.990M |
| March 31, 2016 | -6.855M |
| December 31, 2015 | 6.941M |
| September 30, 2015 | -0.0861M |
| June 30, 2015 | 0.7574M |
| March 31, 2015 | 3.540M |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | |
| June 30, 2013 | -1.245M |
| March 31, 2013 | 0.0162M |
| December 31, 2012 | 6.503M |
| September 30, 2012 | 3.602M |
| June 30, 2012 | -0.0971M |
| March 31, 2012 | 0.097M |
| December 31, 2011 | -0.0297M |
| September 30, 2011 | -0.0674M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.017M
Minimum
Sep 2019
76.86M
Maximum
Dec 2019
9.670M
Average
0.152M
Median
Jun 2020
Cash from Financing (Quarterly) Benchmarks
| Perspective Therapeutics Inc | 166.33M |
| Retractable Technologies Inc | -0.1313M |
| Xtant Medical Holdings Inc | 5.179M |
| Asensus Surgical Inc | 0.811M |
| Catheter Precision Inc | -0.11M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -20.86M |
| Cash from Investing (Quarterly) | 15.07M |
| Free Cash Flow | -52.18M |
| Free Cash Flow Per Share (Quarterly) | -0.8618 |
| Free Cash Flow to Equity (Quarterly) | -23.58M |
| Free Cash Flow to Firm (Quarterly) | -20.74M |
| Free Cash Flow Yield | -25.10% |